Clincosm LogoSign in Get a demo

Acute Myelogenous Leukemia

Showing 101 - 125 of 203
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (micafungin, posaconazole)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 4, 2018

Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia Trial in Houston (IL-2)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +9 more
  • IL-2
  • Houston, Texas
  • +1 more
Apr 3, 2018

Acute Myelogenous Leukemia Trial in Minneapolis (IL-15)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • IL-15
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 22, 2018

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Columbus (atorvastatin, Tacrolimus,

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University
Jan 16, 2018

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (CPX-351)

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • New York, New York
    Weill Cornell Medical College
Jan 12, 2018

Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia Trial in United States (HMA, SGN-CD33A)

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • Birmingham, Alabama
  • +13 more
Jan 3, 2018

Acute Myelogenous Leukemia, Refractory Acute Myelogenous Leukemia Trial in Minneapolis (drug, radiation, biological)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Refractory Acute Myelogenous Leukemia
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Acute Myelogenous Leukemia Trial in Minneapolis (biological, drug, procedure, radiation)

Completed
Has Results
  • Acute Myelogenous Leukemia
  • aldesleukin
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia Trial in Minneapolis (90Y-AHN-12)

Terminated
  • Acute Myelogenous Leukemia
  • +3 more
  • 90Y-AHN-12
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Acute Myelogenous Leukemia Trial in Minneapolis, Saint Louis (biological, device, drug)

Withdrawn
  • Acute Myelogenous Leukemia
  • CD3-/CD19- natural killer cells
  • +6 more
  • Minneapolis, Minnesota
  • +1 more
Nov 29, 2017

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Minneapolis (Preparative Regimen, Intravenous Recombinant Human

Completed
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Preparative Regimen
  • Intravenous Recombinant Human IL-15 (rhIL-15)
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 29, 2017

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, B-cell Chronic Lymphocytic Leukemia Trial in Scottsdale, Atlanta,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Nov 16, 2017

Acute Myeloid Leukemia (AML), Acute Myelocytic Leukemia, Acute Myelogenous Leukemia Trial in Boston (Lenalidomide,

Terminated
  • Acute Myeloid Leukemia (AML)
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 15, 2017

Acute Myelogenous Leukemia Trial in France, United States (Inecalcitol, Placebo Oral Tablet)

Unknown status
  • Acute Myelogenous Leukemia
  • San Diego, California
  • +7 more
Jun 30, 2017

Acute Myelogenous Leukemia Trial in Louisville (Vaccine)

Withdrawn
  • Acute Myelogenous Leukemia
  • Vaccine
  • Louisville, Kentucky
    University of Louisville
May 8, 2017

Acute Myelogenous Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disease Trial in São Paulo (ARM A Cyclophosphamide, ARM

Terminated
  • Acute Myelogenous Leukemia
  • +5 more
  • ARM A Cyclophosphamide
  • ARM B Calcineurin inhibitor and methotrexate
  • São Paulo, Brazil
    Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIE
Mar 2, 2017

Refractory Leukemia, Acute Myelogenous Leukemia Trial in Worldwide (Panobinostat/LBH589)

Completed
Has Results
  • Refractory Leukemia
  • Acute Myelogenous Leukemia
  • Chicago, Illinois
  • +39 more
Jan 8, 2017

Acute Myelogenous Leukemia Trial in Boston (Cytarabine, Idarubicin, Alisertib)

Completed
  • Acute Myelogenous Leukemia
  • Boston, Massachusetts
  • +2 more
Feb 15, 2017

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Non-Hodgkins Lymphoma Trial in United States (Food Safety Guidelines,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Food Safety Guidelines
  • Neutropenic Diet
  • San Diego, California
  • +5 more
Feb 7, 2017

Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia With Maturation Trial in Suzhou (anti-CD33 CAR-NK

Unknown status
  • Acute Myelogenous Leukemia
  • +4 more
  • anti-CD33 CAR-NK cells
  • Suzhou, Jiangsu, China
    PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Dec 4, 2016

Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)

Terminated
Has Results
  • Hematologic Malignancy
  • +11 more
  • Total Body Irradiation (TBI)
  • +5 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 19, 2016

Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +8 more
  • Chicago, Illinois
    The University of Chicago
Oct 7, 2016

Childhood Leukemia (Aka The California Childhood Leukemia Study)

Completed
  • Leukemia
  • +3 more
    • Berkeley, California
      University of California, School of Public Health, Childhood Leu
    Oct 11, 2016

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)

    Terminated
    Has Results
    • Acute Myelogenous Leukemia
    • +3 more
    • Baltimore, Maryland
    • +3 more
    Aug 16, 2016

    Acute Myelogenous Leukemia Trial in Nantes (cell therapy product, injection of the cell therapy product)

    Unknown status
    • Acute Myelogenous Leukemia
    • cell therapy product
    • injection of the cell therapy product
    • Nantes, France
      Cellule de Promotion de la recherche clinique
    Jul 25, 2016